Norfloxacin Versus Ciprofloxacin for Spontaneous Bacterial Peritonitis (SBP) Prevention

PHASE4CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

July 31, 2015

Study Completion Date

April 30, 2016

Conditions
Adverse Reaction to Other Drugs and Medicines
Interventions
DRUG

Norfloxacin

Norfloxacin 400 mg per day

DRUG

ciprofloxacin

Ciprofloxacin 750 mg per week

Trial Locations (7)

Unknown

Korea University Ansan Hospital, Ansan

Soonchunhyang University College of Medicine, Bucheon Hospital, Bucheon-si

Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan

Kyungpuk National University Hospital, Daegu

Korea University Anam Hospital, Seoul

Soonchunhyang University College of Medicine, Seoul Hospital, Seoul

Sungkyunkwan University Gangbuk Samsung Hospital, Seoul

All Listed Sponsors
collaborator

Sungkyunkwan University

OTHER

collaborator

Kyungpook National University Hospital

OTHER

collaborator

Soon Chun Hyang University

OTHER

lead

Korea University

OTHER

NCT01542801 - Norfloxacin Versus Ciprofloxacin for Spontaneous Bacterial Peritonitis (SBP) Prevention | Biotech Hunter | Biotech Hunter